Suspension of trading

Income Statement Intra-Cellular Therapies, Inc.

Stocks

ITCI

US46116X1019

Pharmaceuticals

Market Closed - Nasdaq 16:00:00 2025-04-01 EDT			5-day change	1st Jan Change
131.87 ^USD	-0.04%		-.--%	-

25-04-15	J&J Boosts Outlook Despite Incoming Tariff Costs -- Update	DJ
25-04-15	J&J Increases Outlook After Beating 1Q Expectations	DJ

09ad06d54.6Kldn6v9cDEu0PTpugXStB-NxEjZGRJRsTBLiYnFYZY.2swxzPmeSUVhu5CLw2Cj2W_EvQbpa0cS21Q7_bmTUdGq7jrV07AqXwOXkw

Published financial data: INTRA-CELLULAR THERAPIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Revenues	22.81M	83.8M	250M	464M	681M
Total Revenues	22.81M	83.8M	250M	464M	681M
Cost of Goods Sold, Total	67.68M	96.88M	155M	214M	293M
Gross Profit	-44.86M	-13.08M	95.16M	250M	388M
Selling General & Admin Expenses, Total	186M	273M	359M	410M	504M
Other Operating Expenses, Total	186M	273M	359M	410M	504M
Operating Income	-231M	-286M	-264M	-159M	-117M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	4.24M	1.57M	7.38M	20.34M	42.52M
Net Interest Expenses	4.24M	1.57M	7.38M	20.34M	42.52M
EBT, Excl. Unusual Items	-227M	-284M	-256M	-139M	-74.2M
EBT, Incl. Unusual Items	-227M	-284M	-256M	-139M	-74.2M
Income Tax Expense	13.51K	5.63K	6K	636K	473K
Earnings From Continuing Operations	-227M	-284M	-256M	-140M	-74.68M
Net Income to Company	-227M	-284M	-256M	-140M	-74.68M
Net Income - (IS)	-227M	-284M	-256M	-140M	-74.68M
Net Income to Common Incl Extra Items	-227M	-284M	-256M	-140M	-74.68M
Net Income to Common Excl. Extra Items	-227M	-284M	-256M	-140M	-74.68M
Per Share Items
Net EPS - Basic	-3.23	-3.5	-2.72	-1.46	-0.72
Basic EPS - Continuing Operations	-3.23	-3.5	-2.72	-1.46	-0.72
Basic Weighted Average Shares Outstanding	70.36M	81.25M	94.05M	95.88M	103M
Net EPS - Diluted	-3.23	-3.5	-2.72	-1.46	-0.72
Diluted EPS - Continuing Operations	-3.23	-3.5	-2.72	-1.46	-0.72
Diluted Weighted Average Shares Outstanding	70.36M	81.25M	94.05M	95.88M	103M
Normalized Basic EPS	-2.02	-2.19	-1.7	-0.91	-0.45
Normalized Diluted EPS	-2.02	-2.19	-1.7	-0.91	-0.45
American Depositary Receipts Ratio (ADR)	0.17	0.17	0.17	0.17	0.17
Supplemental Items
EBITDA	-231M	-285M	-263M	-159M	-116M
EBITA	-231M	-286M	-264M	-159M	-117M
EBIT	-231M	-286M	-264M	-159M	-117M
EBITDAR	-227M	-282M	-256M	-151M	-108M
Total Revenues (As Reported)	22.81M	83.8M	250M	464M	681M
Effective Tax Rate - (Ratio)	-0.01	-0	-0	-0.46	-0.64
Current Domestic Taxes	-	-	-	636K	473K
Total Current Taxes	13.51K	5.63K	6K	636K	473K
Deferred Domestic Taxes	-	-	-	0	0
Total Deferred Taxes	0	0	0	0	0
Normalized Net Income	-142M	-178M	-160M	-86.9M	-46.38M
Supplemental Operating Expense Items
Advertising Expense	36.3M	82.5M	85.8M	92.2M	101M
Selling and Marketing Expenses	36.3M	82.5M	85.8M	92.2M	101M
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	65.78M	88.85M	135M	180M	236M
Net Rental Expense, Total	3.3M	3.3M	7.2M	7.68M	8.24M
Stock-Based Comp., COGS (Total)	8.41M	11.46M	17.18M	17.39M	21.4M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	15.7M	22.85M	25.84M	35.44M	42.63M
Stock-Based Comp., Other (Total)	214K	179K	90K	92K	82K
Total Stock-Based Compensation	24.33M	34.48M	43.1M	52.92M	64.12M

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Assets
Cash And Equivalents	60.05M	92.36M	149M	148M	307M
Short Term Investments	597M	320M	443M	350M	694M
Total Cash And Short Term Investments	657M	412M	592M	498M	1B
Accounts Receivable, Total	10.76M	20.16M	75.19M	114M	166M
Other Receivables	-	-	-	-	5M
Total Receivables	10.76M	20.16M	75.19M	114M	172M
Inventory	7.06M	7.95M	23.92M	11.65M	26.28M
Prepaid Expenses	14.24M	25.44M	23.59M	27.34M	68.46M
Restricted Cash	1.4M	1.4M	1.75M	1.75M	1.75M
Other Current Assets, Total	-	-	21.6M	15.1M	38.3M
Total Current Assets	691M	467M	738M	668M	1.31B
Gross Property Plant And Equipment	30.36M	27.12M	21.96M	-	-
Accumulated Depreciation	-4.04M	-4.57M	-5.22M	-	-
Net Property Plant And Equipment	26.32M	22.56M	16.74M	14.58M	14.9M
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	86.08K	86.08K	86K	45.91M	44.65M
Total Assets	717M	490M	755M	728M	1.37B
Liabilities
Accounts Payable, Total	5.5M	8.69M	10.4M	11.45M	26.07M
Accrued Expenses, Total	25.81M	37.93M	68.27M	108M	175M
Current Portion of Leases	5.54M	6.73M	4.57M	3.61M	4.23M
Total Current Liabilities	36.85M	53.36M	83.24M	124M	206M
Long-Term Leases	23.6M	18.67M	15.47M	13.33M	12.75M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	60.45M	72.03M	98.71M	137M	218M
Common Stock, Total	8.05K	8.19K	9K	10K	11K
Additional Paid In Capital	1.59B	1.64B	2.14B	2.21B	2.84B
Retained Earnings	-937M	-1.22B	-1.48B	-1.62B	-1.69B
Comprehensive Income and Other	481K	-364K	-4.19M	104K	191K
Total Common Equity	657M	418M	656M	591M	1.15B
Total Equity	657M	418M	656M	591M	1.15B
Total Liabilities And Equity	717M	490M	755M	728M	1.37B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	80.92M	93.59M	95.28M	96.81M	106M
ECS Total Common Shares Outstanding	80.46M	81.89M	94.83M	96.38M	106M
Book Value / Share	8.16	5.1	6.92	6.14	10.81
Tangible Book Value	657M	418M	656M	591M	1.15B
Tangible Book Value Per Share	8.16	5.1	6.92	6.14	10.81
Total Debt	29.14M	25.41M	20.04M	16.94M	16.98M
Net Debt	-628M	-387M	-572M	-481M	-984M
Debt Equivalent Oper. Leases	26.4M	26.4M	57.63M	61.48M	65.93M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	2.48M	2.48M	17.23M	-	-
Inventories - Work In Process, Total	1.78M	2.41M	2.59M	-	14.97M
Inventories - Finished Goods, Total	2.79M	3.06M	4.1M	-	11.31M
Machinery, Total	4.79M	5.12M	5.9M	-	-
Full Time Employees	383	512	561	610	860
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	120K	-	-	-	-

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Net Income	-227M	-284M	-256M	-140M	-74.68M
Depreciation & Amortization - CF	528K	533K	656K	528K	508K
Depreciation & Amortization, Total	528K	533K	656K	528K	508K
(Gain) Loss on Sale of Investments - (CF)	-648K	-4.08M	447K	-8.4M	-9.03M
Stock-Based Compensation (CF)	24.33M	34.48M	43.1M	52.92M	64.12M
Change In Accounts Receivable	-10.76M	-9.39M	-55.03M	-38.83M	-52.48M
Change In Inventories	-7.06M	-892K	-15.97M	-26.35M	-14.9M
Change In Accounts Payable	-1.92M	3.19M	1.7M	1.06M	14.62M
Change In Deferred Taxes	265K	-	-	-	-
Change in Other Net Operating Assets	-7.8M	741K	11.16M	34.54M	-1.33M
Cash from Operations	-230M	-260M	-270M	-124M	-73.18M
Capital Expenditure	-267K	-326K	-778K	-269K	-322K
Investment in Marketable and Equity Securities, Total	-480M	281M	-128M	106M	-335M
Cash from Investing	-480M	280M	-128M	106M	-335M
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	664M	11.52M	455M	17.81M	568M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	664M	11.52M	455M	17.81M	568M
Net Change in Cash	-46.19M	32.32M	56.6M	-848K	159M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	1.6K	5.63K	6K	162K	1.82M
Levered Free Cash Flow	-149M	-150M	-181M	-28.97M	-63.55M
Unlevered Free Cash Flow	-149M	-150M	-181M	-28.97M	-63.55M
Change In Net Working Capital	28.87M	6.18M	59.06M	-17.46M	54.9M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Profitability
Return on Assets	-29.84	-29.58	-26.47	-13.43	-6.96
Return on Total Capital	-31.97	-31.62	-29.44	-15.51	-8.23
Return On Equity %	-53.3	-52.87	-47.72	-22.39	-8.58
Return on Common Equity	-53.3	-52.87	-47.72	-22.39	-8.58
Margin Analysis
Gross Profit Margin %	-196.66	-15.6	38.01	53.94	56.95
SG&A Margin	816.92	325.3	143.33	88.26	74.1
EBITDA Margin %	-1.01K	-340.27	-105.06	-34.21	-17.07
EBITA Margin %	-1.01K	-340.9	-105.32	-34.32	-17.14
EBIT Margin %	-1.01K	-340.9	-105.32	-34.32	-17.14
Income From Continuing Operations Margin %	-995.07	-339.04	-102.37	-30.08	-10.97
Net Income Margin %	-995.07	-339.04	-102.37	-30.08	-10.97
Net Avail. For Common Margin %	-995.07	-339.04	-102.37	-30.08	-10.97
Normalized Net Income Margin	-621.88	-211.9	-63.98	-18.71	-6.81
Levered Free Cash Flow Margin	-652.24	-179.04	-72.25	-6.24	-9.33
Unlevered Free Cash Flow Margin	-652.24	-179.04	-72.25	-6.24	-9.33
Asset Turnover
Asset Turnover	0.05	0.14	0.4	0.63	0.65
Fixed Assets Turnover	0.97	3.43	12.74	29.65	46.19
Receivables Turnover (Average Receivables)	-	5.42	5.25	4.91	4.85
Inventory Turnover (Average Inventory)	-	12.91	9.74	12.03	15.45
Short Term Liquidity
Current Ratio	18.75	8.76	8.87	5.41	6.36
Quick Ratio	18.13	8.11	8.01	4.95	5.7
Operating Cash Flow to Current Liabilities	-6.24	-4.86	-3.25	-1.01	-0.36
Days Sales Outstanding (Average Receivables)	-	67.34	69.51	74.36	75.4
Days Outstanding Inventory (Average Inventory)	-	28.26	37.48	30.35	23.68
Average Days Payable Outstanding	-	26.49	20.35	19.78	22.32
Cash Conversion Cycle (Average Days)	-	69.11	86.64	84.93	76.76
Long Term Solvency
Total Debt/Equity	4.44	6.08	3.05	2.86	1.48
Total Debt / Total Capital	4.25	5.73	2.96	2.78	1.46
LT Debt/Equity	3.59	4.47	2.36	2.25	1.11
Long-Term Debt / Total Capital	3.44	4.21	2.29	2.19	1.09
Total Liabilities / Total Assets	8.43	14.7	13.08	18.79	15.98
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	-0.13	-0.09	-0.08	-0.11	-0.16
Net Debt / EBITDA	2.76	1.37	2.24	3.18	9.11
Total Debt / (EBITDA - Capex)	-0.13	-0.09	-0.08	-0.11	-0.16
Net Debt / (EBITDA - Capex)	2.76	1.37	2.23	3.18	9.09
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	37.54K	267.35	198.69	85.51	46.62
Gross Profit, 1 Yr. Growth %	-49.63	-70.85	-827.66	163.23	54.81
EBITDA, 1 Yr. Growth %	50.26	23.6	-7.78	-39.59	-26.84
EBITA, 1 Yr. Growth %	50.14	23.55	-7.72	-39.54	-26.77
EBIT, 1 Yr. Growth %	50.14	23.55	-7.72	-39.54	-26.77
Earnings From Cont. Operations, 1 Yr. Growth %	53.67	25.16	-9.81	-45.49	-46.54
Net Income, 1 Yr. Growth %	53.67	25.16	-9.81	-45.49	-46.54
Normalized Net Income, 1 Yr. Growth %	53.66	25.17	-9.81	-45.74	-46.63
Diluted EPS Before Extra, 1 Yr. Growth %	20.52	8.39	-22.08	-46.54	-50.29
Accounts Receivable, 1 Yr. Growth %	-	87.24	273.04	51.64	46.03
Inventory, 1 Yr. Growth %	-	12.64	200.96	-51.31	125.66
Net Property, Plant and Equip., 1 Yr. Growth %	28.33	-14.31	-25.79	-12.88	2.15
Total Assets, 1 Yr. Growth %	185.57	-31.7	54.06	-3.51	87.69
Tangible Book Value, 1 Yr. Growth %	236.84	-36.38	57	-9.85	94.19
Common Equity, 1 Yr. Growth %	236.84	-36.38	57	-9.85	94.19
Cash From Operations, 1 Yr. Growth %	79.77	12.81	4.1	-54.03	-41.08
Capital Expenditures, 1 Yr. Growth %	-61.92	22.13	139.38	-65.42	19.7
Levered Free Cash Flow, 1 Yr. Growth %	92.82	0.84	20.53	-83.98	119.35
Unlevered Free Cash Flow, 1 Yr. Growth %	92.82	0.84	20.53	-83.98	119.35
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	3.62K	231.25	135.4	64.92
Gross Profit, 2 Yr. CAGR %	-41.74	-61.68	45.64	337.66	101.87
EBITDA, 2 Yr. CAGR %	19.37	36.28	6.77	-25.36	-33.52
EBITA, 2 Yr. CAGR %	19.37	36.2	6.78	-25.31	-33.46
EBIT, 2 Yr. CAGR %	19.37	36.2	6.78	-25.31	-33.46
Earnings From Cont. Operations, 2 Yr. CAGR %	20.97	38.69	6.25	-29.89	-46.02
Net Income, 2 Yr. CAGR %	20.97	38.69	6.25	-29.89	-46.02
Normalized Net Income, 2 Yr. CAGR %	20.97	38.69	6.25	-30.05	-46.19
Diluted EPS Before Extra, 2 Yr. CAGR %	6.66	14.29	-8.1	-35.46	-48.45
Accounts Receivable, 2 Yr. CAGR %	-	-	164.29	137.84	48.81
Inventory, 2 Yr. CAGR %	-	-	84.12	21.05	4.82
Net Property, Plant and Equip., 2 Yr. CAGR %	376.41	4.86	-20.26	-19.59	-5.66
Total Assets, 2 Yr. CAGR %	41.71	39.66	2.58	21.92	34.57
Tangible Book Value, 2 Yr. CAGR %	43.79	46.39	-0.06	18.96	32.31
Common Equity, 2 Yr. CAGR %	43.79	46.39	-0.06	18.96	32.31
Cash From Operations, 2 Yr. CAGR %	39.53	42.41	8.37	-30.82	-47.96
Capital Expenditures, 2 Yr. CAGR %	-17.44	-31.8	70.7	-9.02	-35.67
Levered Free Cash Flow, 2 Yr. CAGR %	51.55	39.44	10.24	-56.06	-40.72
Unlevered Free Cash Flow, 2 Yr. CAGR %	51.55	39.44	10.24	-56.06	-40.72
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	352.74	-	1.5K	173.04	101.03
Gross Profit, 3 Yr. CAGR %	-17.25	-53.75	2.23	77.4	209.52
EBITDA, 3 Yr. CAGR %	31	20.77	19.65	-11.7	-25.86
EBITA, 3 Yr. CAGR %	31.01	20.75	19.62	-11.67	-25.8
EBIT, 3 Yr. CAGR %	31.01	20.75	19.62	-11.67	-25.8
Earnings From Cont. Operations, 3 Yr. CAGR %	32.42	22.35	20.16	-14.95	-35.94
Net Income, 3 Yr. CAGR %	32.42	22.35	20.16	-14.95	-35.94
Normalized Net Income, 3 Yr. CAGR %	31.94	22.35	20.15	-15.07	-36.08
Diluted EPS Before Extra, 3 Yr. CAGR %	15.07	7.24	0.59	-23.28	-40.84
Accounts Receivable, 3 Yr. CAGR %	-	-	-	119.61	102.15
Inventory, 3 Yr. CAGR %	-	-	-	18.18	48.98
Net Property, Plant and Equip., 3 Yr. CAGR %	184.99	168.92	-6.55	-17.87	-12.92
Total Assets, 3 Yr. CAGR %	15.01	11.11	44.3	0.51	40.78
Tangible Book Value, 3 Yr. CAGR %	13.07	9.57	49.84	-3.44	40.07
Common Equity, 3 Yr. CAGR %	13.07	9.57	49.84	-3.44	40.07
Cash From Operations, 3 Yr. CAGR %	41.92	29.99	28.28	-18.58	-34.43
Capital Expenditures, 3 Yr. CAGR %	-28.29	-5.93	3.56	0.25	-0.31
Levered Free Cash Flow, 3 Yr. CAGR %	46.77	32.31	32.83	-42.04	-24.9
Unlevered Free Cash Flow, 3 Yr. CAGR %	46.77	32.31	32.83	-42.04	-24.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	201.63	202.53	299.55	-	545.8
Gross Profit, 5 Yr. CAGR %	-12.53	-32.53	3.75	13.64	34.21
EBITDA, 5 Yr. CAGR %	16.9	19.29	20.71	-0.38	-5.42
EBITA, 5 Yr. CAGR %	16.92	19.29	20.72	-0.36	-5.39
EBIT, 5 Yr. CAGR %	16.92	19.29	20.72	-0.36	-5.39
Earnings From Cont. Operations, 5 Yr. CAGR %	16.72	19.53	21.25	-2.08	-12.75
Net Income, 5 Yr. CAGR %	16.72	19.53	21.25	-2.08	-12.75
Normalized Net Income, 5 Yr. CAGR %	16.72	19.75	20.99	-2.17	-12.86
Diluted EPS Before Extra, 5 Yr. CAGR %	2.08	5.37	5.18	-12.47	-23.01
Accounts Receivable, 5 Yr. CAGR %	222.91	192.38	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	102.37	104.7	71.23	65.92	-6.2
Total Assets, 5 Yr. CAGR %	8.18	4.73	9.87	15.31	40.33
Tangible Book Value, 5 Yr. CAGR %	6.64	2.16	7.62	13.23	42.56
Common Equity, 5 Yr. CAGR %	6.64	2.16	7.62	13.23	42.56
Cash From Operations, 5 Yr. CAGR %	17.6	23.25	27.4	1	-10.58
Capital Expenditures, 5 Yr. CAGR %	-20.89	46.08	1.47	-7.22	-14.39
Levered Free Cash Flow, 5 Yr. CAGR %	17.37	24.27	30.9	-14.87	-3.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	17.37	24.28	30.9	-14.87	-3.81